Overview

Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever

Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to impove the pharmacological treatment of Rocky mountain spotted fever, since is a very ancient disease with an antibiotic therapy that have not changed much the mortality rates, being compared with the natural curse of the disease.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital General de Mexicali
Treatments:
Azithromycin
Doxycycline